Gap Scanner
·
Stocks gapping ≥20% at open — earnings flagged, AI catalyst research included
| Ticker | Company | Sector | MCap | Prev Close | Open | Gap% | Earnings | Type | Conf | Key Detail |
|---|---|---|---|---|---|---|---|---|---|---|
| FLNC | Fluence Energy, Inc. | Utilities | 3.5B | $13.56 | $19.20 | +41.6% | AMC | contract | 8 | Order intake doubled year-to-date to $2.0 billion (vs $1.0 billion prior year); signed master supply agreements with two major hyperscalers with first order expected Q3 FY2026; backlog reached record $5.6 billion as of March 31, 2026 |
| SITM | SiTime Corporation | Technology | 21.0B | $623.33 | $835.05 | +34.0% | AMC | beat | 8 | Q1 2026 revenue of $113.6M (88.3% YoY growth vs $60.3M in Q1 2025); non-GAAP EPS of $1.44 per diluted share; non-GAAP gross margin expanded to 64.5% from 57.4% YoY; non-GAAP operating income of $31.8M vs $2.1M in Q1 2025 |
| OSG | Octave Specialty Group, Inc. | Financial Services | 273M | $4.22 | $5.35 | +26.8% | AMC | beat | 8 | Insurance Distribution segment delivered 92% revenue growth to $78.5 million (vs. $41.0 million in 1Q25), with Adjusted EBITDA surging 256% to $25.3 million to shareholders; company reported Adjusted net income of $0.37 per diluted share vs. loss of $(0.13) per share in 1Q25, driven by ArmadaCare acquisition (October 2025) and 42% organic revenue growth. |
| FLEX | Flex Ltd. | Technology | 48.9B | $96.45 | — | +24.3% | BMO | guidance | 9 | FY2027 adjusted EPS guidance raised to $4.21-$4.51 (32% growth at midpoint) vs FY2026 adjusted EPS of $3.30; FY2027 revenue guidance $32.3-$33.8 billion (18% growth at midpoint) vs FY2026 revenue of $27.9 billion; announced planned spin-off of Cloud and Power Infrastructure segment |
| PCT | PureCycle Technologies, Inc. | Industrials | 1.6B | $7.62 | $9.32 | +22.3% | AMC | partner | 8 | Procter & Gamble (P&G) final approval for commercialization of two applications with PureFive resin; first P&G application qualified and slated for first pellet delivery in Q2 2026; second application expected to ship in 2H 2026. Joint product quality study showed PureCycle process achieves highest CosPaTox purity rating. |
8–10 = trade signal
5–7 = research more
0–4 = stay out / no clear catalyst
Orange sector = Healthcare (binary event risk)
· Hover sector for industry · Hover ticker for price chart